These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21084807)

  • 1. [A retrospective survey on allergic reactions by oxaliplatin].
    Honda S; Yoshimura M; Ohno K; Yamamoto E; Kitada N; Hashida T; Imagawa F
    Gan To Kagaku Ryoho; 2010 Nov; 37(11):2101-4. PubMed ID: 21084807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective analysis of the risk factors for allergic reactions induced by the administration of oxaliplatin.
    Yamauchi H; Goto T; Takayoshi K; Sagara K; Uoi M; Kawanabe C; Matsunaga M; Miyoshi T; Uchino K; Misumi N; Nishino T
    Eur J Cancer Care (Engl); 2015; 24(1):111-6. PubMed ID: 24304429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypersensitivity Reactions to Oxaliplatin: Identifying the Risk Factors and Judging the Efficacy of a Desensitization Protocol.
    Okayama T; Ishikawa T; Sugatani K; Yoshida N; Kokura S; Matsuda K; Tsukamoto S; Ihara N; Kuriu Y; Nakanishi M; Nakamura T; Kamada K; Katada K; Uchiyama K; Takagi T; Handa O; Konishi H; Yagi N; Naito Y; Otsuji E; Hosoi H; Miki T; Itoh Y
    Clin Ther; 2015 Jun; 37(6):1259-69. PubMed ID: 25862137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of allergic reactions to oxaliplatin].
    Arii D; Ikeno Y; Murooka K; Nojima M; Kidokoro A
    Gan To Kagaku Ryoho; 2012 Apr; 39(4):593-7. PubMed ID: 22504684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and risk factors of oxaliplatin-related hypersensitivity reactions.
    Shao YY; Hu FC; Liang JT; Chiu WT; Cheng AL; Yang CH
    J Formos Med Assoc; 2010 May; 109(5):362-8. PubMed ID: 20497869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypersensitivity reactions to oxaliplatin: a retrospective study and the development of a desensitization protocol.
    Syrigou EI; Karapanagiotou EM; Alamara CV; Boura PG; Saif MW; Syrigos KN
    Clin Colorectal Cancer; 2009 Apr; 8(2):106-9. PubMed ID: 19739272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergic-type reactions to oxaliplatin: retrospective analysis of 42 patients.
    Maindrault-Goebel F; André T; Tournigand C; Louvet C; Perez-Staub N; Zeghib N; De Gramont A
    Eur J Cancer; 2005 Oct; 41(15):2262-7. PubMed ID: 16154353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of allergic reactions to oxaliplatin in colorectal cancer patients.
    Suenaga M; Mizunuma N; Shinozaki E; Matsusaka S; Chin K; Muto T; Konishi F; Hatake K
    J Support Oncol; 2008; 6(8):373-8. PubMed ID: 19149322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of reintroducing oxaliplatin to patients with colorectal cancer after mild hypersensitivity reactions.
    Park SJ; Lee KY; Park WS; Min SY
    Oncology; 2013; 85(6):323-7. PubMed ID: 24247529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of local reactions to oxaliplatin infusions by peripheral versus central venous administration.
    To YY; Sutcliffe KJ; Hoen HM; Swaney RA; Nicholls JD; Crocenzi TS
    J Oncol Pharm Pract; 2016 Apr; 22(2):256-60. PubMed ID: 25762052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypersensitivity and idiosyncratic reactions to oxaliplatin.
    Bhargava P; Gammon D; McCormick MJ
    Cancer; 2004 Jan; 100(1):211-2. PubMed ID: 14692042
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypersensitivity to oxaliplatin: an investigation of incidence and risk factors, and literature review.
    Kim BH; Bradley T; Tai J; Budman DR
    Oncology; 2009; 76(4):231-8. PubMed ID: 19246947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxaliplatin-associated hypersensitivity reactions: clinical presentation and management.
    Hewitt MR; Sun W
    Clin Colorectal Cancer; 2006 Jul; 6(2):114-7. PubMed ID: 16945166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse reactions to oxaliplatin: a retrospective study of 25 patients treated in one institution.
    Lenz G; Hacker UT; Kern W; Schalhorn A; Hiddemann W
    Anticancer Drugs; 2003 Oct; 14(9):731-3. PubMed ID: 14551506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypersensitivity reactions to oxaliplatin: what nurses need to know.
    Bonosky K; Miller R
    Clin J Oncol Nurs; 2005 Jun; 9(3):325-30. PubMed ID: 15973843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersensitivity reactions to oxaliplatin: experience in a single institute.
    Siu SW; Chan RT; Au GK
    Ann Oncol; 2006 Feb; 17(2):259-61. PubMed ID: 16282245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergic reactions to oxaliplatin in a single institute in Japan.
    Ichikawa Y; Goto A; Hirokawa S; Kijima M; Ishikawa T; Chishima T; Suwa H; Yamamoto H; Yamagishi S; Osada S; Ota M; Fujii S
    Jpn J Clin Oncol; 2009 Sep; 39(9):616-20. PubMed ID: 19556337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience.
    Polyzos A; Tsavaris N; Gogas H; Souglakos J; Vambakas L; Vardakas N; Polyzos K; Tsigris C; Mantas D; Papachristodoulou A; Nikiteas N; Karavokyros JG; Felekouras E; Griniatsos J; Giannopoulos A; Kouraklis G
    Oncology; 2009; 76(1):36-41. PubMed ID: 19033714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful rechallenge for oxaliplatin hypersensitivity reactions in patients with metastatic colorectal cancer.
    Yanai T; Iwasa S; Hashimoto H; Kato K; Hamaguchi T; Yamada Y; Shimada Y; Yamamoto H
    Anticancer Res; 2012 Dec; 32(12):5521-6. PubMed ID: 23225461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Analysis of Hypersensitivity Reactions to Oxaliplatin Among Colorectal Cancer Patients.
    Shen Y; Li C; Liu W; Mao W; Qian H; Wang H; Xu Q
    Oncol Res; 2018 Jun; 26(5):801-807. PubMed ID: 29295722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.